Adam Singolda is listed as a director on 10 SEC Form D filings by 1 issuer between Nov 2016 and Aug 2026: K Health, Inc. (New York, NY — other technology — 2016–2026; $132M reported sold to 26 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Allon Bloch (10 shared filings), Mark Tluszcz (10 shared filings), Alejandro Zubillaga (7 shared filings), Antonio Gracias (2 shared filings), Chen Yehudai (2 shared filings) and 11 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Adam. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 10 public filings for Adam Singolda and found 5 differences, 1 worth asking the sponsor about: 4 Form Ds were filed more than 15 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.